209 related articles for article (PubMed ID: 17409435)
1. IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3.
Carlo-Stella C; Guidetti A; Di Nicola M; Lavazza C; Cleris L; Sia D; Longoni P; Milanesi M; Magni M; Nagy Z; Corradini P; Carbone A; Formelli F; Gianni AM
Cancer Res; 2007 Apr; 67(7):3269-75. PubMed ID: 17409435
[TBL] [Abstract][Full Text] [Related]
2. The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.
Carlo-Stella C; Di Nicola M; Turco MC; Cleris L; Lavazza C; Longoni P; Milanesi M; Magni M; Ammirante M; Leone A; Nagy Z; Gioffrè WR; Formelli F; Gianni AM
Cancer Res; 2006 Feb; 66(3):1799-808. PubMed ID: 16452241
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
[TBL] [Abstract][Full Text] [Related]
4. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
5. The in vitro biological activity of the HLA-DR-binding clinical IgG4 antibody 1D09C3 is a consequence of the disruption of cell aggregates and can be abrogated by Fab arm exchange.
Hansen K; Ruttekolk IR; Glauner H; Becker F; Brock R; Hannus S
Mol Immunol; 2009 Oct; 46(16):3269-77. PubMed ID: 19699529
[TBL] [Abstract][Full Text] [Related]
6. A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients.
Kuranda K; Berthon C; Dupont C; Wolowiec D; Leleu X; Polakowska R; Jouy N; Quesnel B
Exp Hematol; 2010 Feb; 38(2):124-31. PubMed ID: 19948206
[TBL] [Abstract][Full Text] [Related]
7. Regulation of monocyte/macrophage C2 production and HLA-DR expression by IL-4 (BSF-1) and IFN-gamma.
Littman BH; Dastvan FF; Carlson PL; Sanders KM
J Immunol; 1989 Jan; 142(2):520-5. PubMed ID: 2492049
[TBL] [Abstract][Full Text] [Related]
8. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
[TBL] [Abstract][Full Text] [Related]
9. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
[TBL] [Abstract][Full Text] [Related]
10. CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice.
Carlo-Stella C; Guidetti A; Di Nicola M; Longoni P; Cleris L; Lavazza C; Milanesi M; Milani R; Carrabba M; Farina L; Formelli F; Gianni AM; Corradini P
Exp Hematol; 2006 Jun; 34(6):721-7. PubMed ID: 16728276
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones.
Piguet V; Carrel S; Diserens AC; Mach JP; de Tribolet N
J Natl Cancer Inst; 1986 Feb; 76(2):223-8. PubMed ID: 3080635
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human leukocyte antigen expression in human conjunctival epithelium.
Tsubota K; Fukagawa K; Fujihara T; Shimmura S; Saito I; Saito K; Takeuchi T
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):28-34. PubMed ID: 9888423
[TBL] [Abstract][Full Text] [Related]
13. Modulation of carcinoembryonic antigen messenger RNA levels in human colon carcinoma cells by recombinant human gamma-interferon.
Kantor J; Tran R; Greiner J; Pestka S; Fisher PB; Shively JE; Schlom J
Cancer Res; 1989 May; 49(10):2651-5. PubMed ID: 2496918
[TBL] [Abstract][Full Text] [Related]
14. Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study.
Schweighofer CD; Tuchscherer A; Sperka S; Meyer T; Rattel B; Stein S; Ismail S; Elter T; Staib P; Reiser M; Hallek M
Cancer Immunol Immunother; 2012 Dec; 61(12):2367-73. PubMed ID: 23090290
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
Kooy AJ; Prens EP; Van Heukelum A; Vuzevski VD; Van Joost T; Tank B
J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
Wang YD; Hu Y; Zhang L; Huang J; Sun CY
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169
[TBL] [Abstract][Full Text] [Related]
17. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells.
Ranella A; Vassiliadis S; Mastora C; Valentina M; Dionyssopoulou E; Athanassakis I
Hum Immunol; 2005 Jan; 66(1):43-55. PubMed ID: 15620461
[TBL] [Abstract][Full Text] [Related]
18. A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment.
Sekimoto E; Ozaki S; Ohshima T; Shibata H; Hashimoto T; Abe M; Kimura N; Hattori K; Kawai S; Kinoshita Y; Yamada-Okabe H; Tsuchiya M; Matsumoto T
Cancer Res; 2007 Feb; 67(3):1184-92. PubMed ID: 17283154
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody to the NH2-terminal segment of human IFN-gamma selectively interferes with the antiproliferative activity of the lymphokine.
Caruso A; Tiberio L; De Rango C; Bonfanti C; Flamminio G; Gribaudo G; Monti E; Viani E; Manca N; Garotta G
J Immunol; 1993 Feb; 150(3):1029-35. PubMed ID: 8423329
[TBL] [Abstract][Full Text] [Related]
20. Induction of HLA-DR expression in human lamina cribrosa astrocytes by cytokines and simulated ischemia.
Yang J; Yang P; Tezel G; Patil RV; Hernandez MR; Wax MB
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):365-71. PubMed ID: 11157868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
